HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

George Garibaldi Selected Research

N- ((3S)- 1- azabicyclo(2.2.2)oct- 3- yl)- 1H- indazole- 3- carboxamide hydrochloride

6/2014A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


George Garibaldi Research Topics

Disease

4Schizophrenia (Dementia Praecox)
01/2017 - 06/2014
1Major Depressive Disorder (Major Depressive Disorders)
10/2014
1Bipolar Disorder (Manic Depressive Psychosis)
10/2014

Drug/Important Bio-Agent (IBA)

4Antipsychotic Agents (Antipsychotics)IBA
01/2017 - 06/2014
3(4- (3- fluoro- 5- trifluoromethylpyridin- 2- yl)piperazin- 1- yl)(5- methanesulfonyl- 2- (2,2,2- trifluoro- 1- methylethoxy)phenyl)methanoneIBA
01/2017 - 06/2014
1Antidepressive Agents (Antidepressants)IBA
10/2014
1Paliperidone PalmitateFDA Link
06/2014
1Glycine (Aminoacetic Acid)FDA LinkGeneric
06/2014
1Aripiprazole (Abilify)FDA Link
06/2014
1N- ((3S)- 1- azabicyclo(2.2.2)oct- 3- yl)- 1H- indazole- 3- carboxamide hydrochlorideIBA
06/2014
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
06/2014
1Risperidone (Risperdal Consta)FDA LinkGeneric
06/2014